Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent L Chen

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Hepatology Communications|March 4, 2024
Pour some sugar on me: Glycemic control and the prevention of liver diseaseVincent L Chen, Jennifer A Flemming
Journal of Chemical Biology|July 2, 2009
Brought to life: targeted activation of enzyme function with small moleculesAnthony C Bishop, Vincent L Chen
Hepatology International|October 5, 2021
Are herbals more hepatotoxic than prescription medications?Vincent L Chen, Robert J Fontana
Hepatology Communications|January 8, 2025
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical applicationVincent L Chen, Graham F Brady
Gut Microbes|January 15, 2014
Interactions between the intestinal microbiota and innate lymphoid cellsVincent L Chen, Dennis L Kasper
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2024
Integrating PNPLA3 into clinical risk predictionVincent L Chen, Umberto Vespasiani-Gentilucci
Chemical Communications (Cambridge, England)|January 12, 2010
Chemical rescue of protein tyrosine phosphatase activityVincent L Chen, Anthony C Bishop
Alimentary Pharmacology & Therapeutics|April 13, 2023
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' replyKarn Wijarnpreecha, Anna S Lok, Vincent L Chen
JAMA Network Open|August 5, 2024
Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US AdultsAlisa Likhitsup, Vincent L Chen, Robert J Fontana
Clinical and Molecular Hepatology|April 27, 2026
Predictive modeling and clinical decision tools for risk stratification in steatotic liver diseaseJeanette Girard, Elliot B Tapper, Vincent L Chen
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Hepatology Communications|March 4, 2024
Pour some sugar on me: Glycemic control and the prevention of liver diseaseVincent L Chen, Jennifer A Flemming
Journal of Chemical Biology|July 2, 2009
Brought to life: targeted activation of enzyme function with small moleculesAnthony C Bishop, Vincent L Chen
Hepatology International|October 5, 2021
Are herbals more hepatotoxic than prescription medications?Vincent L Chen, Robert J Fontana
Hepatology Communications|January 8, 2025
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical applicationVincent L Chen, Graham F Brady
Gut Microbes|January 15, 2014
Interactions between the intestinal microbiota and innate lymphoid cellsVincent L Chen, Dennis L Kasper
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2024
Integrating PNPLA3 into clinical risk predictionVincent L Chen, Umberto Vespasiani-Gentilucci
Chemical Communications (Cambridge, England)|January 12, 2010
Chemical rescue of protein tyrosine phosphatase activityVincent L Chen, Anthony C Bishop
Alimentary Pharmacology & Therapeutics|April 13, 2023
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' replyKarn Wijarnpreecha, Anna S Lok, Vincent L Chen
JAMA Network Open|August 5, 2024
Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US AdultsAlisa Likhitsup, Vincent L Chen, Robert J Fontana
Clinical and Molecular Hepatology|April 27, 2026
Predictive modeling and clinical decision tools for risk stratification in steatotic liver diseaseJeanette Girard, Elliot B Tapper, Vincent L Chen
Pageof 13